KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Debt Ratio (2018 - 2025)

Castle Biosciences' Debt Ratio history spans 5 years, with the latest figure at 0.02 for Q4 2025.

  • For Q4 2025, Debt Ratio fell 7.87% year-over-year to 0.02; the TTM value through Dec 2025 reached 0.02, down 7.87%, while the annual FY2025 figure was 0.02, 7.87% down from the prior year.
  • Debt Ratio for Q4 2025 was 0.02 at Castle Biosciences, down from 0.02 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.05 in Q1 2022 and bottomed at 0.0 in Q1 2025.
  • The 3-year median for Debt Ratio is 0.02 (2024), against an average of 0.02.
  • The largest YoY upside for Debt Ratio was 7.87% in 2025 against a maximum downside of 89.85% in 2025.
  • A 3-year view of Debt Ratio shows it stood at 0.05 in 2022, then plummeted by 59.78% to 0.02 in 2024, then decreased by 7.87% to 0.02 in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Debt Ratio are 0.02 (Q4 2025), 0.02 (Q3 2025), and 0.02 (Q2 2025).